'Predictive biomarkers' diaporamas de présentation

Steps on the Road to Predictive Medicine

Steps on the Road to Predictive Medicine. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov. BRB Website brb.nci.nih.gov. Powerpoint presentations Reprints & Presentations Reports BRB-ArrayTools software Web based Sample Size Planning

840 views • 69 slides

LUNG CANCER OMICS

731 views • 57 slides

Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute

Use of Genomics in Clinical Trial Design and How to Critically Evaluate Claims for Prognostic & Predictive Biomarkers. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov. BRB Website brb.nci.nih.gov. Powerpoint presentations Reprints

555 views • 55 slides

Development and Use of Predictive Biomarkers Dr. Richard Simon

Development and Use of Predictive Biomarkers Dr. Richard Simon. Potential Conflict of Interest. None. Development and Use of Predictive Biomarkers. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov.

638 views • 49 slides

Hepatocellular Carcinoma

Hepatocellular Carcinoma. Abby Siegel MD, MS Columbia University Co-Chair, SWOG Hepatobiliary Committee NCI Task Force, Hepatobiliary Cancers. Outline. Epidemiology Biology Staging/Prognosis/Management Future of Targeted Therapy. Outline. Epidemiology Biology

1.06k views • 44 slides

Angiogenesis: Using Old and New Approaches

John Mackey, MD Professor of Oncology University of Alberta Edmonton, Canada. Angiogenesis: Using Old and New Approaches. Faculty Disclosure. John R. Mackey, MD, FRCP (C), has disclosed that he has received consulting fees from Eli Lilly and Roche and CME honoraria from Amgen. Overview.

1.02k views • 42 slides

Emerging Biomarkers of Acute Kidney Injury (AKI)

1.31k views • 35 slides

Improving Quality of Trials through the MRC Network of Hubs for Trials Methodology Research

Improving Quality of Trials through the MRC Network of Hubs for Trials Methodology Research. Professor Lucinda (Cindy) Billingham Professor of Biostatistics Director, MRC Midland Hub for Trials Methodology Research Biostatistics Lead, Cancer Research UK Clinical Trials Unit

551 views • 33 slides

Predictive Biomarkers of EGFR Targeted Therapy: Beyond KRAS

565 views • 31 slides

Vascular Injury Expert Working Group 19 July NCSS Report

Vascular Injury Expert Working Group 19 July NCSS Report. Committee Members David Essayan-CBER Don Robertson-Pfizer Fred Miller-NIEHS Kerry Blanchard-Boehringer-Ingleheim Les Schwartz-GlaxoSmithKline-CoChair Paul Snyder-Purdue Prakash Nagarkatti-Virginia Commonwealth Univ.

424 views • 26 slides

WELCOME TO THE NEW YORK T SC CONFERENCE

WELCOME TO THE NEW YORK T SC CONFERENCE. May 5, 2013. TUBEROUS SCLEROSIS COMPLEX SCIENCE & MEDICAL UPDATE. Steve Roberds, Ph.D. Chief Scientific Officer 5 March 2013. TSC Clinical Consensus Conference Update recommended diagnosis, surveillance, & management.

265 views • 10 slides